Ibáñez-Sanz, Gemma http://orcid.org/0000-0001-6071-7343
Guinó, Elisabet
Pontes, Caridad
Quijada-Manuitt, Mª Ángeles
de la Peña-Negro, Luisa C
Aragón, María
Domínguez, Marga
Rodríguez-Alonso, Lorena
Blasco, Alex
García-Rodríguez, Ana
Morros, Rosa
Moreno, Victor http://orcid.org/0000-0002-2818-5487
Funding for this research was provided by:
Bioibérica SA
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI14-00613)
Bioiberica SA
Article History
Received: 6 September 2018
Accepted: 30 August 2019
First Online: 19 September 2019
Competing Interests
: The corresponding authors (V.M., R.M.) have received funding from Bioiberica, S.A., Barcelona to study epidemiological evidence of drugs associated to CRC. The authors acted with complete independence of this company that has no statins or lipid lowering drug in their portfolio.